Skip to main content
SpringerLink
Log in

Medication Management

  • Chapter
  • First Online:
Geriatrics for Specialists

  • 1089 Accesses

Abstract

Optimizing medication management is often a major challenge for clinicians caring for older persons. Age-related changes in pharmacokinetics and pharmacodynamics, the large number of co-occurring chronic diseases, and consequent polypharmacy lead to prescribing challenges. To minimize adverse medication events, address polypharmacy, and improve medication management when caring for older patients, several tactics and resources will be discussed. These include pharmacist-directed services; clinical resources to address potentially inappropriate medication use and medication underuse, namely, the American Geriatrics Society (AGS) Beer’s Criteria, Screening Tool of Older Person’s Prescriptions (STOPP), Screening Tool to Alert to Right Treatment (START), and US Fit fOR The Aged (US-FORTA); principles for managing older adults with multimorbidity; as well as principles of deprescribing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. 2018 Profile of Older Americans. Administration for Community Living. https://acl.gov/aging-and-disability-in-america/data-and-research/profile-older-americans. Accessed 15 July 2020.

  2. Center for Medicare and Medicaid Services. Chronic conditions overview; chartbook and charts, chronic condition charts. 2017. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/Chartbook_Charts. Accessed 15 July 2020.

  3. Freedman VA. The demography of late-life disability. In: Hayward M, Majmudar MK, editors. Future directions for the demography of aging. Washington DC: National Academics Press; 2018. p. 179–200. https://doi.org/10.17226/25064.

    Chapter  Google Scholar 

  4. Lassman D, Hartman M, Washington B, Andrews K, Catlin A. US health spending trends by age and gender: selected years 2002-10. Health Aff. 2014;33(5):815–22.

    Article  Google Scholar 

  5. Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473–82.

    Article  Google Scholar 

  6. Orwig D, Rickles NM, Martin LG. Methodological issues in pharmacotherapy research in older adults. Am J Geriatr Pharmcother. 2011;9(3):173–89.

    Article  Google Scholar 

  7. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother. 2007;5(1):31–9.

    Article  Google Scholar 

  8. Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother. 2018;52(9):829–37.

    Article  Google Scholar 

  9. Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Liu GG, Perri M. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care. 2007;45:472–6.

    Article  Google Scholar 

  10. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging research conference on frailty in older adults. J Am Geriatr Soc. 2006;54:991–1001.

    Article  Google Scholar 

  11. Rowe JW, Kahn RL. Human aging: usual and successful. Science. 1987;237:143–9.

    Article  CAS  Google Scholar 

  12. Higbee MD. The geriatric patient: general physiologic and pharmacologic considerations. J Pharm Pract. 2000;18(4):250–62.

    Article  Google Scholar 

  13. Aspinall SL, Springer SP, Zhao X, Cunningham FE, Thorpe CT, Semla TP, Shorr RI, Hanlon JT. Central nervous system medication burden and risk of recurrent serious falls and hip fractures in veterans affairs nursing home residents. J Am Geriatr Soc. 2019;67:74–80. https://doi.org/10.1111/jgs.15603.

    Article  PubMed  Google Scholar 

  14. Fox C, Smith T, Maidment I, Chan WY, Bua N, Myint PK, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014;43:604–15. https://doi.org/10.1093/ageing/afu096.

    Article  PubMed  Google Scholar 

  15. Hanlon JT, Semla TP, Schmader KE. Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc. 2015;63:e8.

    Article  Google Scholar 

  16. American Geriatrics Society Beers Criteria® Update Expert Panel, Fick DM, Semla TP, et al. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.

    Article  Google Scholar 

  17. Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J. 2009;85:322–6.

    Article  CAS  Google Scholar 

  18. Klausner SC, Schwartz AB. The aging heart. Clin Geriatr Med. 1985;1(1):119–41.

    Article  CAS  Google Scholar 

  19. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14. https://doi.org/10.1046/j.1365-2125.2003.02007.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67–76. https://doi.org/10.1080/03602530902722679.

    Article  CAS  PubMed  Google Scholar 

  21. Creatinine Clearance Calculator. Available at: http://reference.medscape.com/calculator/creatinine-clearance-cockcroft-gault. Accessed 9 Aug 2020.

  22. Masnoon N, Shakib S, Kalisch-Ellet L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230–40.

    Article  Google Scholar 

  23. Taghy N, Cambon L, Cohen JM, Dussart C. Failure to reach a consensus in polypharmacy definition: an obstacle to measuring risks and impacts—results of a literature review. Ther Clin Risk Manag. 2020;16:57–73.

    Article  Google Scholar 

  24. Levy HB. Polypharmacy reduction strategies, tips on incorporating American Geriatrics Society beers and screening tool of older people’s prescriptions criteria. Clin Geriatr Med. 2017;33:177–87.

    Article  Google Scholar 

  25. Maher RL, Hanlon JT, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014l;13:57–65.

    Article  Google Scholar 

  26. Garber J, Brownlee S. Medication overload: America’s other drug problem. Brookline: The Lown Institute; 2019.

    Book  Google Scholar 

  27. Fried TR, Mecca MC. Medication appropriateness in vulnerable older adults: healthy skepticism of appropriate polypharamacy. J Am Geriatr Soc. 2019;67:1123–7.

    Article  Google Scholar 

  28. Monane M, Monane S, Semla T. Optimal medication use in elders. Key to successful aging. Western J Med. 1997;167:233–7.

    CAS  Google Scholar 

  29. Fried TR, O’Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261–72.

    Article  Google Scholar 

  30. Palmer K, Villani ER, Vetrano DL, Cherubini A, Cruz-Jentoft AJ, Curtin D, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med. 2019;10:9–36. https://doi.org/10.1007/s41999-018-0124-5

    Article  Google Scholar 

  31. Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidie NJ, Budnitz DS. US emergency department visits for outpatient adverse drug events, 2013-2014. J Am Med Assoc. 2016;316:2115–25. https://doi.org/10.1001/jama.2016.16201.

    Article  Google Scholar 

  32. Taché SV, Sӧnnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother. 2011;45:977–89. https://doi.org/10.1345/aph.1P627.

    Article  PubMed  Google Scholar 

  33. Kanaan AO, Donovan JL, Duchin NP, et al. Adverse drug events post-hospital discharge in older patients: types, severity, and involvement of Beers criteria medications. J Am Geriatr Soc. 2013;61:1894–9.

    Article  Google Scholar 

  34. Field T, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005;43:1171–6.

    Article  Google Scholar 

  35. Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7:11–22. https://doi.org/10.1177/2042098615615472.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Davies EA, O’Mahony MS. Adverse drug reactions in special populations—the elderly. Br J Clin Pharmacol. 2015;80:796–807. https://doi.org/10.1111/bcp.12596.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN report: emergency department visits involving adverse reactions to medications among older adults. Rockville, MD. February 24, 2011.

    Google Scholar 

  38. Budnitz D, Lovegrove M, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–12.

    Article  CAS  Google Scholar 

  39. Marcum ZA, Hanlon JT, Murray MD. Improving medication adherence and health outcomes in older adults: an evidence-based review of randomized controlled trials. Drug Aging. 2017;34:191–201.

    Article  Google Scholar 

  40. MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA. Assessing medication adherence in the elderly, which tools to use in clinical practice? Drugs Aging. 2005;22(3):231–55.

    Article  Google Scholar 

  41. Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44.

    PubMed  PubMed Central  Google Scholar 

  42. Gurwitz J, Field T, Harrold L, Rothschild J, Debellis K, Seger A, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. J Am Med Assoc. 2003;289(9):1107–16.

    Article  Google Scholar 

  43. Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc. 2011;59(8):1513–20. https://doi.org/10.1111/j.1532-5415.2011.03500.x.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Joint Commission of Pharmacy Practitioners. Pharmacists’ Patient Care Process. May 29, 2014. https://jcpp.net/patient-care-process/. Accessed 14 August 2020.

  45. Lee JK, Slack MK, Martin J, Ehrman C, Chisholm-Burns M. Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses. J Am Geriatr Soc. 2013;61(7):1119–27. https://doi.org/10.1111/jgs.12323.

    Article  PubMed  Google Scholar 

  46. Walsh KA, O’Riordan D, Kearney PM, Timmons S, Byrne S. Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists’ interventions in secondary care. Age Ageing. 2016;45:201–9. https://doi.org/10.1093/ageing/afv190.

    Article  PubMed  Google Scholar 

  47. O’Sullivan D, O’Mahony D, O’Connor MN, Gallagher P, Gallagher J, Cullinan S, et al. Prevention of adverse drug reactions in hospitalized older patients using a software-supported structured pharmacist intervention: a cluster randomize controlled trial. Drugs Aging. 2016;33:63–73. https://doi.org/10.1007/s40266-015-0329-y.

    Article  CAS  PubMed  Google Scholar 

  48. Nguyen PV, Martinez AV. Impact of pharmacist interventions in an ambulatory geriatric care clinic: the IMPACC study. Sr Care Pharm. 2020;34:230–6.

    Article  Google Scholar 

  49. Tilton JJ, Edakkunnathu MG, Moran KM, Vaysman AM, DaPisa JL, Goen BM, et al. Impact of a medication therapy management clinic on glycosylated hemoglobin, blood pressure, and resource utilization. Ann Pharmacother. 2019;53:13–20. https://doi.org/10.1177/1060028018794860.

    Article  PubMed  Google Scholar 

  50. Jacobs M, Sherry PS, Taylro LM, Amato M, Tataronis GR, Cushing G. Pharmacist assisted medication program enhancing the regulation of diabetes (PAMPERED) study. J Am Pharm Assoc. 2012;52:613–21. https://doi.org/10.1331/JAPhA.2012.10183.

    Article  Google Scholar 

  51. Gray SL, Hart LA, Perera S, Semla TP, Schmader KE, Hanlon JT. Meta-analysis of interventions to reduce adverse drug reactions. J Am Geriatr Soc. 2018;66:282–8. https://doi.org/10.1111/jgs.15195.

    Article  PubMed  Google Scholar 

  52. Cobb CD. Optimizing medication use with a pharmacist-provided comprehensive medication management service for patients with psychiatric disorders. Pharmacotherapy. 2014;34:1336–40. https://doi.org/10.1002/phar.1503.

    Article  PubMed  Google Scholar 

  53. Pellagrin KL, Krenk L, Oakes SJ, Ciarleglio A, Lynn J, McInnis T, et al. Reductions in medication-related hospitalizations in older adults with medication management by hospital and community pharmacists: a quasi-experimental study. J Am Geriatr Soc. 2017;65:212–9. https://doi.org/10.1111/jgs.14518.

    Article  Google Scholar 

  54. Gray C, Cooke CE, Brandt N. Evolution of the Medicare Part D medication therapy management program from inception in 2006 to the present. Am Health Drug Benefits. 2019 Sep;12(5):243–51.

    PubMed  PubMed Central  Google Scholar 

  55. U.S. National Library of Medicine. What is pharmacogenomics? https://ghr.nlm.nih.gov/primer/genomicresearch/pharmacogenomics. Accessed 23 July 2020.

  56. U.S. Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling. Accessed 26 July 2020.

  57. Caudle KE, Klein TE, Hoffman JM, et al. Incorporation of pharmacogenomics into routine clinical practice: the clinical pharmacogenetics implementation consortium (CPIC) guideline development process. Curr Drug Metab. 2014;15(2):209–17.

    Article  CAS  Google Scholar 

  58. Clinical Pharmacogenetics Implementation Consortium (CPIC). Guidelines. https://cpicpgx.org/guidelines/. Accessed 26 March 2020.

  59. Wang YT, Merl MY, Yang J, Zhu ZX, Li GH. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice. Pharmacogenomics J. 2019;20:169–78. https://doi.org/10.1038/s41397-019-0119-8.

    Article  CAS  PubMed  Google Scholar 

  60. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8. https://doi.org/10.1093/ageing/afu145.

    Article  PubMed  Google Scholar 

  61. Curtin D, Gallagher PF, O’Mahony D. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019;10:1–10. https://doi.org/10.1177/2042098619829431.

    Article  Google Scholar 

  62. O’Mahony D, Gudmundsson A, Soiza RL, Petrovic M, Jose Cruz-Jentoft A, Cherubni A, et al. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR randomized controlled clinical trial. Age Ageing 2020;49:605–14.

    Google Scholar 

  63. Dalton K, Curtin D, O’Mahony D, Byrne S. Computer-generated STOPP/START recommendations for hospitalised older adults: evaluation of the relationship between clinical relevance and rate of implementation in the SENATOR trial. Age Ageing 2020;49:615–21.

    Google Scholar 

  64. Xing XX, Zhu C, Liang HY, Wang K, Chu YQ, Zhao LB, et al. Associations between potentially inappropriate medications and adverse health outcomes in the elderly: a systematic review and meta-analysis. Ann Pharmacother. 2019;53(10):1005–19. https://doi.org/10.1177/1060028019853069.

    Article  PubMed  Google Scholar 

  65. Weir DL, Lee TC, McDonald EG, Motulsky A, Abrahamowicz M, Morgan S, et al. Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events. J Am Geriatr Soc. 2020;68:1184–92. https://doi.org/10.1111/jgs.16413.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Clark CM, Shaver AL, Aurelio LA, Feuerstein S, Wahler RG Jr, Daly CJ, et al. Potentially inappropriate medications are associated with increased healthcare utilization and costs. J Am Geriatr Soc. 2020;68(11):2542–50. https://doi.org/10.1111/jgs.16743.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Pazan F, Gercke Y, Weiss C, Wehling M, FORTA Raters. The US-FORTA (Fit fOR The Aged) list: consensus validation of a clinical tool to improve drug therapy in older adults. J Am Med Dir Assoc. 2020;21:439.e9–e13. https://doi.org/10.1016/j.jamda.2019.07.023.

    Article  Google Scholar 

  68. Wehling M, Burkhardt H, Kuhn-Thiel A, Pazan F, Throm C, Weiss C, et al. VALFORTA: a randomized trial to validate the FORTA (fit fOR the aged) classification. Age Ageing. 2016;45:262–7. https://doi.org/10.1093/ageing/afv200.

    Article  PubMed  Google Scholar 

  69. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc. 2012;60(10):E1–E25. https://doi.org/10.1111/j.1532-5415.2012.04188.x.

  70. Boyd C, Smith CD, Masoudi FA, Blaum CS, Dodson JA, Green AR, Kelley A, Matlock D, Ouellet J, Rich MW, Schoenborn NL, Tinetti ME. Decision making for older adults with multiple chronic conditions: executive summary for the American Geriatrics Society guiding principles on the care of older adults with multimorbidity. J Am Geriatr Soc. 2019;67:665–73. https://doi.org/10.1111/jgs.15809.

    Article  PubMed  Google Scholar 

  71. Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.

    Article  Google Scholar 

  72. Brandt N, Stefanacci R. Discontinuation of unnecessary medications in older adults. Consult Pharm. 2011;26:845–54.

    Article  Google Scholar 

  73. Currow DC, Stevenson JP, Abernethy AP, et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55(4):590–5.

    Article  Google Scholar 

  74. Sheppard JP, Burt J, Lown M, et al. Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older: the OPTIMISE randomized clinical trial. J Am Med Assoc. 2020;323(20):2039–51. https://doi.org/10.1001/jama.2020.4871.

    Article  CAS  Google Scholar 

  75. Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166(6):605–9.

    Article  Google Scholar 

  76. Bain KT, Holmes HM, Beers MH, Maio V, et al. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56(10):1946–52.

    Article  Google Scholar 

  77. Holmes HM, Min LC, Yee M, et al. Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging. 2013;30(9):655–66.

    Article  Google Scholar 

  78. Case SM, O’Leary J, Kim N, Tinetti ME, Fried TR. Older adults’ recognition of trade-offs in healthcare decision-making. J Am Geriatr Soc. 2015;63(8):1658–62.

    Article  Google Scholar 

  79. Kutner JS, Blatchford PJ, Taylor DH Jr, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015;175(5):691–700.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lamy Center on Drug Therapy and Aging and Department of Pharmacy Practice and Science, University of Maryland, School of Pharmacy, Baltimore, MD, USA

    Nicole J. Brandt

  2. HbL PharmaConsulting, Saint Louis, MO, USA

    Hedva Barenholtz Levy

Authors
  1. Nicole J. Brandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hedva Barenholtz Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicole J. Brandt .

Editor information

Editors and Affiliations

  1. Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA

    Andrew G. Lee

  2. Home Instead Center for Successful Aging, University of Nebraska Medical Center, Omaha, NE, USA

    Jane F. Potter

  3. San Francisco VA Health Care System, University of California, San Francisco, San Francisco, CA, USA

    G. Michael Harper

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Brandt, N.J., Levy, H.B. (2021). Medication Management. In: Lee, A.G., Potter, J.F., Harper, G.M. (eds) Geriatrics for Specialists. Springer, Cham. https://doi.org/10.1007/978-3-030-76271-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-76271-1_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-76270-4

  • Online ISBN: 978-3-030-76271-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation